Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Domchek

Showing results (161-170 of 361) with videos related to

Pageof 37
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancersErica L Carpenter, Rosemarie Mick, Andrew J Rech, et al.
Molecular Genetics & Genomic Medicine|August 4, 2019
Research participants' experiences with return of genetic research results and preferences for web-based alternativesJill B Gaieski, Linda Patrick-Miller, Brian L Egleston, et al.
British Journal of Cancer|December 9, 2022
Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer: final results from Study 10Rebecca S Kristeleit, Yvette Drew, Amit M Oza, et al.
Cancer Research|November 3, 2007
Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillanceSusan M Domchek, Adri Recio, Rosemarie Mick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2021
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in <i>BRCA1</i>, <i>BRCA2</i>, or <i>PALB2</i>Kim A Reiss, Rosemarie Mick, Mark H O'Hara, et al.
The Lancet. Oncology|March 3, 2006
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort studySusan M Domchek, Tara M Friebel, Susan L Neuhausen, et al.
Cancer Discovery|December 28, 2012
Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancerSusan M Domchek, Jiangbo Tang, Jill Stopfer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 4, 2015
Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testingAngela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2019
Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast CancerAdam A Kraya, Kara N Maxwell, Bradley Wubbenhorst, et al.
JCO Clinical Cancer Informatics|August 28, 2023
Development of an Electronic Health Record-Based Clinical Decision Support Tool for Patients With Lynch SyndromeKelsey S Lau-Min, Joseph Bleznuck, Colin Wollack, et al.
Pageof 37

Showing results (161-170 of 361) with videos related to

Sort By:
Pageof 37
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancersErica L Carpenter, Rosemarie Mick, Andrew J Rech, et al.
Molecular Genetics & Genomic Medicine|August 4, 2019
Research participants' experiences with return of genetic research results and preferences for web-based alternativesJill B Gaieski, Linda Patrick-Miller, Brian L Egleston, et al.
British Journal of Cancer|December 9, 2022
Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer: final results from Study 10Rebecca S Kristeleit, Yvette Drew, Amit M Oza, et al.
Cancer Research|November 3, 2007
Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillanceSusan M Domchek, Adri Recio, Rosemarie Mick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2021
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in <i>BRCA1</i>, <i>BRCA2</i>, or <i>PALB2</i>Kim A Reiss, Rosemarie Mick, Mark H O'Hara, et al.
The Lancet. Oncology|March 3, 2006
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort studySusan M Domchek, Tara M Friebel, Susan L Neuhausen, et al.
Cancer Discovery|December 28, 2012
Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancerSusan M Domchek, Jiangbo Tang, Jill Stopfer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 4, 2015
Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testingAngela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2019
Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast CancerAdam A Kraya, Kara N Maxwell, Bradley Wubbenhorst, et al.
JCO Clinical Cancer Informatics|August 28, 2023
Development of an Electronic Health Record-Based Clinical Decision Support Tool for Patients With Lynch SyndromeKelsey S Lau-Min, Joseph Bleznuck, Colin Wollack, et al.
Pageof 37